Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By

Immunotherapy for Melanoma: How It Works and What To Expect

Medically reviewed by Alfredo Chua, M.D.
Posted on November 11, 2026

Key Takeaways

  • Immunotherapy is a type of treatment that helps the immune system recognize and fight melanoma cancer cells, and for people with advanced melanoma, it may help slow or stop cancer from growing and even help people live longer.
  • There are several types of immunotherapy available for melanoma, including immune checkpoint inhibitors, interleukin-2, tumor-infiltrating lymphocyte therapy, and oncolytic virus therapy, each working in different ways to target cancer cells. Immunotherapy can be used at different points in a treatment journey, such as before or after surgery, or when melanoma cannot be removed surgically or has come back after treatment.
  • If you or someone you care about has melanoma, talking with a healthcare provider about which immunotherapy options may be appropriate, along with the possible benefits and side effects, can help in making a treatment plan that fits personal health needs and goals.
  • View all takeaways

Your immune system has one job — protecting your body from harm. What if you could use your body’s own immune system to help fight melanoma? Immunotherapy helps your immune system better recognize melanoma cancer cells and fight back more effectively.

For people with advanced melanoma, immunotherapy can help slow or stop cancer from growing. These treatments work in different ways to target cancer cells in the body. They may even help people with advanced melanoma live longer.

This article discusses how different types of immunotherapies for melanoma work, when your doctor may recommend them, and what you can expect in your treatment journey.

🗳️ Have you used one or more immunotherapies to fight your melanoma?
Immune checkpoint inhibitors such as Keytruda, Yervoy, or Tecentriq
Tumor-infiltrating lymphocyte (TIL) therapy
Oncolytic virus therapy
More than one of these

Types of Immunotherapy Available for Melanoma

Several types of immunotherapies are available for the treatment of advanced melanoma, including immune checkpoint inhibitors, interleukin-2, tumor-infiltrating lymphocyte (TIL) therapy, and oncolytic virus therapy.

Immune Checkpoint Inhibitors

Your immune system uses checkpoint proteins as “brakes” to keep your immune system cells from attacking when they’re no longer needed. Cancer cells can use these same “brakes” to hide from the immune system.

Checkpoint inhibitors are medications that block these brakes, making it easier for your immune system to recognize and attack cancer cells. There are several types of immune checkpoint inhibitors used to treat melanoma that has spread to other parts of the body. Each type targets a different checkpoint protein.

Immune checkpoint inhibitors used to treat melanoma include:

PD-1 inhibitors such as pembrolizumab (Keytruda) and nivolumab (Opdivo)
CTLA-4 inhibitors such as ipilimumab (Yervoy)
LAG-3 inhibitors such as relatlimab, given along with nivolumab, in a combination product called Opdualag
PD-L1 inhibitors such as atezolizumab (Tecentriq), used with two targeted therapy drugs for certain melanomas with a BRAF V600 mutation

Immune checkpoint inhibitors are usually given as an intravenous (IV) infusion. Some forms are injected into the fat under the skin. How often you receive treatment depends on the medication and your treatment plan.

Interleukin-2

Interleukin-2 (IL-2) is an immune system protein that increases the activity and production of immune cells. A laboratory-made form called aldesleukin (Proleukin) can be used to help boost the immune system against melanoma.

High-dose IL-2, given in a hospital or specialized treatment center, has been used to treat advanced melanoma. However, it can cause serious side effects. Newer immunotherapies are used more often and are generally easier to tolerate.

IL-2 is typically given as an IV infusion. It can also be directly injected into the tumor in certain situations. This is called intralesional therapy.

Tumor-Infiltrating Lymphocyte Therapy

Tumor-infiltrating lymphocyte (TIL) therapy is a treatment that harnesses certain immune cells called T lymphocytes or T cells. These cells are already in the melanoma tumor, trying to fight the cancer.

Lifileucel (Amtagvi) is a type of TIL therapy for adults with melanoma that can’t be removed with surgery or has spread. It’s used after treatment with a PD-1 inhibitor and, if the melanoma has a BRAF V600 mutation, a BRAF inhibitor. It’s the first TIL therapy to be approved.

The treatment process for TIL therapy has several steps, which include:

The melanoma tumor is removed during surgery and sent to a laboratory.
The TILs are collected and separated out to grow in the laboratory over a few weeks.
You receive chemotherapy for about a week to prepare your body for the TIL infusion.
The TILs are given as an IV infusion in the hospital. IL-2 is then given afterward to help the infused cells grow.
Once in the body, the TILs will help attack the melanoma cells.

Oncolytic Virus Therapy

“Oncolytic” refers to anything that kills or damages cancer cells. Oncolytic viruses are modified in a laboratory to invade and destroy cancer cells. They also help alert the immune system to fight the cancer cells.

There are two oncolytic viruses used for advanced melanoma:

  • Talimogene laherparepvec (Imlygic, T-VEC)
  • Vusolimogene oderparepvec-wtpg (Tudriqev) — Approved by the U.S. Food and Drug Administration (FDA) for use with nivolumab in adults whose melanoma can’t be removed by surgery and has worsened after PD-1 inhibitor treatment

When oncolytic viruses are used depends on the specific treatment and your melanoma. They’re injected directly into a tumor.

When Is Immunotherapy Used for Melanoma?

Immunotherapy can be recommended as a treatment option at several different points in your treatment journey. It depends on how far the cancer has spread, whether or not it can be removed completely with surgery, and your overall health.

Immunotherapy is often used to treat stage 3 and stage 4 melanoma. It may also be recommended for earlier stages when there’s a higher risk of the cancer coming back.

Quote icon

“I just completed my 20th month of immunotherapy. I was diagnosed with stage 4 metastatic melanoma. So far, things are going well. My tumors in my right lung and right hip are gone.”

— A MyMelanomaTeam member

Here are some situations in which immunotherapy may be an option:

  • After surgery — If you’re at a higher risk of the melanoma returning after it’s been removed, immunotherapy may be an option to help lower the risk. This is called adjuvant treatment.
  • Before surgery — For some people with stage 3 melanoma, immunotherapy may be given to help shrink the tumor before surgery. This is called neoadjuvant therapy.
  • Unresectable melanoma — When melanoma can’t be removed completely with surgery, immune checkpoint inhibitors are often a treatment option.
  • Recurrent melanoma — If melanoma comes back after treatment, your doctor may recommend immunotherapy based on where the cancer has spread and your overall health.

There may also be details about your tumor cells, such as specific gene mutations, that can help guide your doctor on treatment options. For example, testing for a change in a gene called BRAF can help your doctor choose a targeted therapy that targets this mutation.

What To Expect With Immunotherapy

Immunotherapy can be given in different ways, depending on the treatment.

Some immunotherapies are only given a limited number of times, such as ipilimumab. Other immunotherapies may be continued for up to a year or longer if they’re working and are well tolerated. TIL therapy is different and only given as a one-time infusion.

Ask your doctor what to expect before your first immunotherapy treatment.

What Is the Goal of Immunotherapy?

The goal of immunotherapy in advanced melanoma is to slow the growth of the tumor, shrink it, and help you live longer while having a better quality of life. Many people respond very well to immunotherapy, and its effects may last for years.

Quote icon

“My last immunotherapy was two years ago, and there’s no evidence of any recurrence. Also, the scientific community continues to find treatments. It gives me hope that if I have a recurrence, there will be an effective one for me, and I can watch my grandkids grow up!”

— A MyMelanomaTeam member

However, immunotherapy doesn’t work for everyone. Doctors can’t always predict how your body will respond to treatment. Even if you’re feeling better, continue to follow up with your doctor and have the scans they recommend.

Side Effects of Immunotherapy

The side effects of immunotherapy depend on which treatment you’re on. If you’re taking a combination therapy, such as ipilimumab plus nivolumab, side effects may be more severe.

Read more details about the side effects of immunotherapy.

Talk to Your Doctor

There are several immunotherapy treatment options for advanced melanoma. The best choice depends on your personal melanoma treatment journey and overall health.

Ask your doctor which treatments may be best for you and why. Asking about the potential benefits, risks, and side effects can help you feel more confident in deciding on a treatment plan.

Tell your doctor about your treatment goals, including what matters to you most. Your preferences and quality of life are important. Together, you and your healthcare team can decide on a treatment plan that fits your needs and goals.

Share this article
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
12,045 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy • Terms of Use
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
12,045 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy • Terms of Use
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In

Thank you for subscribing!

Become a member to get even more

See answer